Fermium Research analyst Frank Mitsch maintains Celanese (NYSE:CE) with a Hold and lowers the price target from $165 to $130.
4 Analysts Have This to Say About Integra Lifesciences
Over the past 3 months, 4 analysts have published their opinion on Integra Lifesciences (NASDAQ:IART) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
